Publications & Multimedia

Cochrane reviews

Cochrane Reviews from READ-It Partners in the Cochrane Database of Systematic Reviews.

Supporting materials

Guidelines

Multimedia resources

Reports

Other publications and stories

View all resources

1

Latest resources

Update:Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria

What are the benefits and risks of atovaquone‐proguanil for treating uncomplicated malaria caused by the Plasmodium falciparum parasite?

Cochrane Systematic Review: UPDATE

Update: Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults

How accurate are tests (Xpert Ultra and Xpert MTB/RIF) for diagnosing tuberculosis outside the lungs (extrapulmonary tuberculosis) and rifampicin resistance?

Cochrane Systematic Review: UPDATE

1

Rapid initiation of antiretroviral therapy for people living with HIV

To assess the effects of rapid initiation of ART (defined as offering ART within seven days of HIV diagnosis) on treatment outcomes and mortality in people living with HIV (PLWH). We also aim to describe the characteristics of rapid ART interventions used in the included studies.

Cochrane Systematic Review: NEW

A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks—results from the Lassa fever pilot

Infectious disease epidemics are a constant threat, and while we can strengthen preparedness in advance, inevitably, we will sometimes be caught unaware by novel outbreaks.

Peer-reviewed article

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults

To determine the diagnostic accuracy of Xpert MTB/RIF and Xpert Ultra for tuberculosis in adults with presumptive PTB, and for rifampicin resistance in adults with presumptive rifampicin‐resistant tuberculosis or MDR‐TB.

Cochrane Systematic Review: UPDATE

Prevention and treatment of acute malnutrition in humanitarian emergencies: a multi-organisation collaboration to increase access to synthesised evidence

This project was designed to make the evidence from relevant systematic reviews about malnutrition as accessible as possible to support evidence-based decision-making and to guide future research on the prevention and treatment of acute malnutrition in humanitarian emergencies.

Peer-reviewed article

Podcast: Vaccines for preventing rotavirus diarrhoea: vaccines in use

Hanna Bergman, one of the authors based in the Cochrane Response team in London UK, to tell us about the problem and the latest findings for this review.

Indoor residual spraying in communities using insecticide‐treated nets for the prevention of malaria

The aim of this review was to summarize the impact of pyrethroid‐like or non‐pyrethroid‐like IRS on malaria, when implemented in communities that are using ITNs.

Cochrane Systematic Review: NEW

Ready‐to‐use therapeutic food (RUTF) for home‐based nutritional rehabilitation of severe acute malnutrition in children from six months to five years of age

To assess the effects of home‐based RUTF used during the rehabilitation phase of SAM in children aged between six months and five years on recovery, relapse, mortality and rate of weight gain

Cochrane Systematic Review: UPDATE

MVA85A vaccine to enhance BCG for preventing tuberculosis

The aim of this Cochrane review was to evaluate the effectiveness and safety of using MVA85A in addition to BCG compared to using BCG alone for the prevention of tuberculosis.

Cochrane Systematic Review: NEW

READ-It Inception Phase Report

Vaccines for preventing rotavirus diarrhoea: vaccines in use

The aim of this Cochrane Review was to find out if rotavirus vaccines are effective in preventing diarrhoea and deaths in infants and young children. We also aimed to find out if the rotavirus vaccines are safe. We collected and analyzed all relevant studies to answer these questions, and found 55 studies.

Cochrane Systematic Review: UPDATE

Diagnosing tuberculosis, Cochrane Special Collections

This Special Collection has been superceded, and the latest version was published 24 March 2020 Tuberculosis (TB) causes more deaths globally than any other infectious disease and is a top 10 cause of death worldwide.

Linezolid for drug‐resistant pulmonary tuberculosis

Recent international guidelines recommend trying to include linezolid in the treatment of all patients with multi‐drug resistant tuberculosis, but there is concern about whether enough good evidence exists to tell us how well it works, what dose is best, and how safe it is for people who take it.

Cochrane Systematic Review: NEW

Pages